» Articles » PMID: 38540299

Linking Periodontitis with Inflammatory Bowel Disease Through the Oral-Gut Axis: The Potential Role of

Overview
Journal Biomedicines
Date 2024 Mar 28
PMID 38540299
Authors
Affiliations
Soon will be listed here.
Abstract

Periodontitis and inflammatory bowel disease (IBD) are both chronic inflammatory diseases that are characterized by abnormal host immune responses and microbiota dysbiosis. Emerging evidence implies potential associations between periodontitis and IBD. (), a primary cause of periodontitis, is thought to play a role in the development of IBD through the oral-gut disease axis. However, the precise mechanisms of its involvement remain enigmatic. In this narrative review, we begin with a discussion of the bidirectional relationship between periodontitis and IBD and the involvement of in each of the two diseases. Further, we summarize the possible routes by which links periodontitis and IBD through the oral-gut axis, as well as the underlying mechanisms of its involvement in the pathogenesis of IBD. Collectively, participates in the progression of IBD through gut dysbiosis, impairment of the intestinal barrier, release of inflammatory mediators, and disturbance of the immune response. The above findings may provide new insights for exploring novel biomarkers and potential therapeutic approaches for IBD.

Citing Articles

Excess dietary sugar and its impact on periodontal inflammation: a narrative review.

Shanmugasundaram S, Karmakar S BDJ Open. 2024; 10(1):78.

PMID: 39379356 PMC: 11461508. DOI: 10.1038/s41405-024-00265-w.

References
1.
Guo Y, Nguyen K, Potempa J . Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins. Periodontol 2000. 2010; 54(1):15-44. PMC: 2924770. DOI: 10.1111/j.1600-0757.2010.00377.x. View

2.
Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

3.
Hooper L, Macpherson A . Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol. 2010; 10(3):159-69. DOI: 10.1038/nri2710. View

4.
Hirschfeld M, Ma Y, Weis J, Vogel S, Weis J . Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol. 2000; 165(2):618-22. DOI: 10.4049/jimmunol.165.2.618. View

5.
Bergstrom K, Kissoon-Singh V, Gibson D, Ma C, Montero M, Sham H . Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog. 2010; 6(5):e1000902. PMC: 2869315. DOI: 10.1371/journal.ppat.1000902. View